Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT00004393
Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
DSM-IV diagnosis of Tourette Syndrome (TS)
Tic symptoms greater than 3 (moderate or worse) on the Global Clinical Impression Scale for TS
--Prior/Concurrent Therapy--
No concurrent use of other medications during study
A minimum of 4 weeks since prior use of other medications and 8 weeks for neuroleptics or fluoxetine
--Patient Characteristics--
Hepatic: No hepatic disease
Renal: No renal disease
Cardiovascular:
* No heart disease
* No hypertension
Pulmonary: No pulmonary disease
Other:
* Not pregnant
* IQ at least 70 required
* No other movement disorder allowed, such as tardive dyskinesia
* No major depression
* No pervasive developmental disorder
* No autism or psychotic disorder based on DSM-IV
* No alcohol or substance abuse
* No hypersensitivity to risperidone
* All subjects must be in good health
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
60 Years
Study:
NCT00004393
Study Brief:
Protocol Section:
NCT00004393